Join
Live feed
·
PRReleasevia Quantisnow
Pulse Biosciences Inc logo

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

ByQuantisnow·Wall Street's wire, on your screen.
PLSE· Pulse Biosciences Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLSE (Pulse Biosciences Inc) and more on Quantisnow.